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Abstract
Methylglyoxal (MGO) is an a-dicarbonyl compound present ubiquitously in the human body. MGO reacts with arginine
residues in proteins and forms adducts such as hydroimidazolone and argpyrimidine in vivo. Previously, we showed that
MGO-mediated modification of aA-crystallin increased its chaperone function. We identified MGO-modified arginine
residues in aA-crystallin and found that replacing such arginine residues with alanine residues mimicked the effects of MGO
on the chaperone function. Arginine 12 (R12) is a conserved amino acid residue in Hsp27 as well as aA- and aB-crystallin.
When treated with MGO at or near physiological concentrations (2–10 mM), R12 was modified to hydroimidazolone in all
three small heat shock proteins. In this study, we determined the effect of arginine substitution with alanine at position 12
(R12A to mimic MGO modification) on the structure and chaperone function of these proteins. Among the three proteins,
the R12A mutation improved the chaperone function of only aA-crystallin. This enhancement in the chaperone function
was accompanied by subtle changes in the tertiary structure, which increased the thermodynamic stability of aA-crystallin.
This mutation induced the exposure of additional client protein binding sites on aA-crystallin. Altogether, our data suggest
that MGO-modification of the conserved R12 in aA-crystallin to hydroimidazolone may play an important role in reducing
protein aggregation in the lens during aging and cataract formation.
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Introduction
Small heat shock proteins are a family of stress proteins. a-
Crystallin and Hsp27 are the major small heat shock proteins in
humans. These proteins are beneficial in preventing cellular
damage for various diseases [1,2,3].
a-Crystallin is a major protein of vertebrate eye lenses, although
its presence in other organs such as the brain, heart, kidney, spleen
and thymus has also been recognized [4,5]. a-Crystallin consists of
two highly homologous subunits, aA- and aB-crystallin, and each
subunit has a molecular weight of ,20 kDa [4]. In the lens aA-
crystallin and aB-crystallin subunits combine in a 3:1 ratio to form
an ,40 mer a-crystallin oligomer [6]. The aB-crystallin gene has a
heat shock promoter element and is induced by various stress
conditions [4,5,7]. aB-Crystallin has been implicated in a number
of neurological disorders, such as Alzheimer’s disease and
Parkinson’s disease [1,8]. Both aA-crystallin and aB-crystallin
can confer cellular thermo-resistance [9]. Both proteins can act as
molecular chaperones, and this chaperoning ability is believed to
play a crucial role in maintaining the transparency of the eye lens
[10]. As a molecular chaperone, a-crystallin not only prevents the
aggregation of unfolded proteins, but it also helps in the refolding
of denatured client proteins [11,12]. Because protein turnover is
virtually absent in the lens, many post-translational modifications
accumulate in lens proteins during aging. Several studies have
shown that these post-translational modifications decrease the
chaperone function of a-crystallin, which might be one reason for
lens aging and age-related cataract formation [13,14,15,16,17].
A large number of advanced glycation end products (AGEs) can
be found in the aged human lens [18], which suggests that
glycation is a major mechanism for post-translational modification
in the aging lens. Glycation is the non-enzymatic reaction that
adds carbohydrates, especially glucose, to proteins. First, glucose
and other sugars react with the amino groups of proteins to form
an unstable Schiff’s base that slowly undergoes rearrangement to
form a relatively stable Amadori product. Through a series of
parallel and sequential reactions (often termed the Maillard
reaction), these Amadori products form many AGEs, some of
which are fluorescent and colored [19,20].
The lens contains relatively high levels of methylglyoxal (MGO).
The reported levels are 1–2 mM [21]. MGO is an a-dicarbonyl
compound that reacts with lysine, arginine and histidine residues
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argpyrimidine [25] and methylglyoxal lysine dimer (MOLD)
[26,27] (Fig. 1). In addition to our own previous findings, others
have reported that the aged and cataractous human lenses contain
more of these MGO-derived AGEs than the normal lens
[25,27,28,29]. Because MGO reacts rapidly with proteins and
the lens proteins have long half-lives, it is reasonable to assume
that cumulative modification by MGO over many decades of life
could be quantitatively significant in the lens proteins.
In general, it is believed that AGE formation is a cause for lens
protein aging and cataract formation. However, we and others
have observed that MGO-AGE formation in aA-crystallin makes
it a better chaperone [30,31]. AGE formation from MGO occurs
predominantly in arginine residues of proteins. Examples of
arginine-derived AGEs caused by MGO glycation are argpyr-
imidine and hydroimidazolone [18]. As a result of these
modifications, arginine residues lose their positive charge and
become neutral. In a previous study, we demonstrated that the loss
of the positive charge was the cause for an increase in the
chaperone function of aA-crystallin. In that study, we replaced
discrete MGO-modifiable arginine residues with a neutral amino
acid, alanine, and showed an improvement in the chaperone
function of the mutant proteins [32]. In addition, the chemical
conversion of lysine residues to homoarginine residues followed by
a reaction with MGO also led to an enhancement in the
chaperone function of aA-crystallin [33].
Unlike a-crystallin, Hsp27 is ubiquitously expressed throughout
the human body. We have shown that Hsp27 is particularly
vulnerable to MGO modification in kidney mesangial cells [34].
Others have shown a similar vulnerability of Hsp27 in other cell
types [35,36]. Furthermore, we showed that the chaperone and
anti-apoptotic functions of Hsp27 were improved after its
modification by MGO [37]. Thus, Hsp27 appears to be a prime
target for MGO modification, and consequently, its function could
be altered in cells.
Altogether, it is clear now that MGO modification of the small
heat shock proteins results in an improvement in their key
functions. Whether the improvement in the chaperone function of
small heat shock proteins occurs via modification of a conserved
arginine residue and whether physiological levels of MGO could
improve the chaperone function through a hydroimidazolone
modification is not known. In this study, we modified human
Hsp27 and aA- and aB-crystallin with 2–10 mM MGO and
identified hydroimidazolone AGEs using mass spectrometry.
Interestingly, the only conserved arginine residue that was
modified to hydroimidazolone by MGO was R12 in all three
proteins. To determine if the hydroimidazolone modification of
this arginine residue is responsible for the improvement of the
Figure 1. MGO reacts with proteins to form AGEs, like, hydroimidazolone, argpyrimidine and MOLD in tissue proteins.
doi:10.1371/journal.pone.0030257.g001
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hydroimidazolone modification) and explored the effect of this
mutation on the structure and chaperone function of Hsp27 and
aA- and aB-crystallin.
Results and Discussion
MGO is derived mostly from triose phosphate intermediates of
glycolysis by non-enzymatic mechanisms in vivo [38]. It is a major
precursor of AGEs in tissue proteins [39]. In previous studies, we
have shown that MGO modifications of small heat shock proteins,
such as aA-crystallin and Hsp27, enhanced their chaperone
function [30,37]. In this study, our primary goal was to determine
whether a similar increase in the chaperone function occurred
with physiological levels of MGO and to determine whether a
modification of the conserved R12 (Fig. 2A) to hydroimidazolone
contributed to the increased chaperone function.
We first determined the ‘‘first hit’’ arginine residues for
modification to hydroimidazolone. To accomplish this, we
modified the proteins with 2, 5 and 10 mM of MGO. With
2 mM MGO, we found that 6, 6 and 8 arginine residues were
modified to hydroimidazolone in aA- and aB-crystallin and
Hsp27, respectively (Table 1). With 10 mM of MGO, this
modification reached 10, 8 and 10 arginine residues in the three
respective proteins. R12 was the only common residues among the
three proteins converted to hydroimidazolone with 2 mM MGO,
which suggested that in small heat shock proteins, R12 is the most
susceptible for modification to hydroimidazolone by MGO.
Notably, a previous study detected a modification of R12 in
human lens aA-crystallin that had a molecular weight identical to
hydroimidazolone [40].
The modification of arginine residues to hydroimidazolone
converts the positive charge on arginine to a neutral charge.
Previously, we reported that the substitution of MGO-modifiable
arginine residues with neutral alanine residues enhanced the
chaperone function of aA-crystallin, similarly to MGO-modifica-
tion [32]. Because R12 is the most susceptible arginine for MGO
modification, we sought to determine if the chaperone function
would be improved if it was replaced with alanine. To accomplish
this, we cloned and expressed the wild-type (Wt) proteins and the
Hsp27R12A, aA-crystallinR12A (aAR12A) and aB-crystallinR12A
(aBR12A) mutant proteins in E. coli BL21(DE3). We then purified
the proteins by sequential chromatographic methods (gel filtration
and ion-exchange chromatography), as previously described [41].
SDS-PAGE analysis showed a single protein band with the correct
molecular weight for all proteins (Fig. 2B).
The chaperone function for the small heat shock proteins was
evaluated using three different client proteins. The aAR12A mutant
showed a 61%, 15% and 10% increase in the chaperone function
compared to the Wt protein with CS, c-crystallin and LDH,
respectively, as client proteins (Fig. 3). Although, aBR12A showed
better protection against thermal aggregation of CS than its Wt
variant (,70% better protective ability), it showed a slight
reduction in the chaperone function against the other two client
proteins tested (Fig. 3B & C). The R12A mutation had no effect on
the chaperone function of Hsp27 (Fig. 3A–C). Previously, Oya-Ito
et al. [37] showed that MGO modification made Hsp27 a better
chaperone. The findings in this study that theR12A mutation did
Figure 2. Sequence alignment and SDS-PAGE of recombinant human Hsp27, aA- and aB-crystallin. (A) Amino-acid sequence alignment
between these three small heat shock proteins was performed using the MULTIPLE SEQUENCE ALIGNMENT program (T-Coffee). (B) SDS-PAGE of
purified proteins. M=Molecular weight markers.
doi:10.1371/journal.pone.0030257.g002
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addition to hydroimidazolone modification, argpyrimidine mod-
ification may be necessary for the improvement of the chaperone
function inHsp27.
To understand the molecular basis behind the enhancement in
the chaperone function of aAR12A, we determined the structural
changes in the protein. Numerous studies have suggested a strong
correlation between the chaperone function and the surface
hydrophobicity of small heat shock proteins [42,43,44,45,46,47],
but others have failed to find such a correlation [48,49]. The
surface hydrophobicity of aAR12A and aBR12A (determined by
TNS binding) were nearly identical to that of their Wt protein
counterparts. Hsp27R12A had a decreased (,65%) surface
hydrophobicity compared to its Wt counterpart (Fig. 4). These
results suggested a lack of correlation between surface hydropho-
bicity and the chaperone function in the three small heat shock
proteins, which is similar to previous reports [48,49].
To assess whether the binding sites of these heat shock proteins
for client proteins were altered by the R12A mutation, we
performed an equilibrium binding study using c-crystallin as the
client protein. We incubated the three heat shock proteins
(12.5 mM each) for 1 hr at 60uC with various concentrations of
c-crystallin (2–18 mM). The unbound (S) and bound c-crystallin
were determined by filtration, as described in Methods and Materials
section. We determined the dissociation constant (Kd) using the
Scatchard equation:
~ v v=S~n=Kd{1=Kd:~ v v,
where ~ v v is the number of moles of the substrate bound per mole of
chaperone, and n is the number of binding site and Kd is the
dissociation constant. The stoichiometry of n and Kd obtained
from the Scatchard plot (Fig. 5) is 3.61 per subunit of aA-crystallin
and 8.44 mM, respectively (Table 2). We noted that the number of
binding sites (n) per subunit of aAR12A increased from 3.61 in Wt
to 4.68, and the association constant increased from 0.118 mM
21
(Kd=8.44 mM) in Wt to 0.124 mM
21 (Kd=8.07 mM) in aAR12A.
The n and Kd values decreased ,25% and ,13%, respectively, in
aBR12A. In contrast, Hsp27R12A showed no changes in either of
these parameters when compared to its Wt counterpart (Table. 2).
From these data, we concluded that the substitution of alanine for
the conserved arginine residue at position 12 of aA-crystallin
Table 1. Identification of HI modification with the treatment of MGO detected by LC-MS/MS.
Protein Peptide Mass (obs.) Mass (cal.)
Modified Arg
residues
Concentration of
MGO (mM)
251 0
aA-crystallin RTLGPFYPSR 1246.6462 1246.6458 R12 X X X
QSLFRTVLDSGISEVR 1859.9809 1859.9741 R54 X
TVLDSGISEVRSDRDK 1829.9117 1829.9119 R65 X X X
SDRDKFVIFLDVK 1634.8756 1634.8668 R68 X X X
HNERQDDHGYISR 1679.7469 1679.7400 R103 X X
QDDHGYISREFHR 1712.7664 1712.7655 R113 X
RYRLPSNVDQSALSCSLSADGMLTFCGPK 3283.5509 3283.5424 R117 X
YRLPSNVDQSALSCSLSADGMLTFCGPK 3143.4382 3143.4362 R119 X X X
IQTGLDATHAERAIPVSR 1988.0434 1988.0439 R157 X X X
AIPVSREEKPTSAPSS 1708.8624 1708.8631 R163 X X X
aB-crystallin RPFFPFHSPSR 1427.7094 1427.7099 R12 X X X
APSWFDTGLSEMRLEK 1935.9078 1935.9036 R69 X X X
LEKDRFSVNLDVK 1615.8580 1615.8569 R74 X X X
HEERQDEHGFISR 1692.7621 1692.7604 R107 X X X
HEERQDEHGFISREFHR 2262.0316 2262.0314 R116 X X
YRIPADVDPLTITSSLSSDGVLTVNGPR 2996.5399 2996.5455 R123 X X
KQVSGPERTIPITR 1634.9041 1634.9104 R157 X X X
TIPITREEKPAVTAAPK 1875.0456 1875.0465 R163 X X X
Hsp27 RVPFSLLR 1040.6157 1040.6131 R5 X X X
VPFSLLRGPSWDPFR 1826.9545 1826.9468 R12 X X X
GPSWDPFRDWYPHSR 1955.8783 1955.8703 R20 X X X
DWYPHSRLFDQAFGLPR 2158.0497 2158.0385 R27 X X X
ALSRQLSSGVSEIR 1555.8312 1555.8318 R79 X X X
QLSSGVSEIRHTADR 1708.8496 1708.8492 R89 X X X
QLSSGVSEIRHTADRWR 2051.0302 2051.0297 R94 X X
WRVSLDVNHFAPDELTVK 2179.1149 2179.1062 R96 X X X
TKDGVVEITGKHEERQDEHGYISR 2836.3729 2836.3740 R127 X
QDEHGYISRCFTR 1721.7586 1721.7580 R136 X X X
doi:10.1371/journal.pone.0030257.t001
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same substitution in aB-crystallin lowered its interaction with the
denatured substrate protein. Our results also demonstrated that
TNS binding sites are different than the client protein binding sites
in all three proteins. We speculate that a structural alteration in
aAR12A exposed additional client protein binding sites, and thus,
aAR12A bound more client proteins and exhibited better
chaperone function than its Wt counterpart.
We used tryptophan (W) fluorescence along with near- and far-
UV CD techniques to determine if there were any changes in the
tertiary and secondary structures of the Wt proteins compared to
the mutant proteins. The intrinsic fluorescence spectra indicated
some differences between Wt and mutant proteins (Fig. 6). The
fluorescence intensity of aAR12A, aBR12A and Hsp27R12A
increased ,27%, 8% and 10%, respectively, compared to the
corresponding Wt proteins. Moreover, the lmax of the tryptophan
fluorescence spectra of the wild-type proteins did not alter due to
the mutation. The changes in fluorescence intensity may reflect
changes in the microenvironment of W9 (in aA- and aB-crystallin)
and W16 (in Hsp27), which are located close to the mutation sites.
The near-UV CD spectra of these three proteins (both wild type
and mutant) agreed with our intrinsic fluorescence data (data not
shown). However, these changes in tryptophan fluorescence
(perturbation in tertiary structure) did not correlate with the
changes in the chaperone function. While some studies showed a
direct relationship between an increase in tryptophan fluorescence
with improved chaperone function, others did not find such a
relationship [33,50,51,52]. Therefore, it is unclear whether
changes in the microenvironment of tryptophan are determinants
of changes in the chaperone function of a-crystallin.
Quantitative analysis of the far-UV CD data using the
CONTINLL program showed that Hsp27 and aA- and aB-
Figure 3. Effect of R12A mutation on the chaperone function of Hsp27, aA- and aB-crystallin. The chaperone function of these three
small heat shock proteins (wild type and mutants)was assessed using three client proteins, as described in Materials and Methods.( A) Citrate synthase
(CS); (B) c-crystallin and (C) Lactate dehydrogenase (LDH).
doi:10.1371/journal.pone.0030257.g003
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no significant perturbation in the secondary structure in the three
proteins as a result of the R12A mutation. Based on these data, we
concluded that the contribution of R12 for the secondary structure
in the three small heat shock proteins was minimal.
Multi-angle light scattering experiments determine the polydis-
persity and the absolute molar mass of proteins. We used this
technique to determine whether the subtle changes in tertiary
structure altered the quaternary structure (i.e., the oligomeric
assembly) of these three small heat shock proteins. From the data
in Table 4, it is evident that a perturbation in the tertiary structure
had little effect on the molecular mass of the mutant proteins. The
hydrodynamic radius (Rh) was slightly increased only with aAR12A
(Table 4). Kundu et al. [53] previously reported that the deletion of
the first 20 amino acid residues in aA-crystallin had no effect in its
oligomeric size, which is analogous to the findings in this study.
The relationship between oligomeric size and chaperone function
of small heat shock proteins is still unclear. Some studies have
Figure 4. Effect of R12A mutation on the surface hydropho-
bicity of Hsp27 and a-crystallin. The surface hydrophobicity of wild
type and mutant proteins was estimated using a hydrophobic probe,
TNS. Protein concentration was 0.1 mg/ml and TNS concentration was
100 mM. The fluorescence spectrum of TNS bound to different samples
at 25uC was recorded from 350–520 nm. The excitation wavelength was
320 nm.
doi:10.1371/journal.pone.0030257.g004
Figure 5. Binding constant of wild type and R12A mutants of
Hsp27, aA- and aB-crystallin for c-crystallin. Binding parameters
for the interaction between c-crystallin and different small heat shock
proteins at 60uC were estimated from Scatchard plot.
doi:10.1371/journal.pone.0030257.g005
Table 2. Determination of the number of binding sites (n)
and dissociation constant (Kd) values for the interaction of
human Hsp27 and aA-and aB-crystallin and their R12A
mutants with c-crystallin at 60uC.
System studied n Kd (mM)
aAWt+c-crystallin 3.6160.07 8.4460.42
aAR12A+c-crystallin 4.6860.09 8.0760.28
aBWt+c-crystallin 2.3460.11 2.8460.12
aBR12A+c-crystallin 1.6860.07 3.2460.17
Hsp27Wt+c-crystallin 2.9060.08 5.9160.23
Hsp27R12A+c-crystallin 2.8760.13 5.7960.35
doi:10.1371/journal.pone.0030257.t002
Figure 6. Intrinsic tryptophan fluorescence spectra of wild type
and mutant (R12A) Hsp27, aA- and aB-crystallin. Tryptophan
fluorescence spectra of different samples (0.1 mg/ml protein) were
recorded from 310–400 nm at 25uC. The excitation wavelength was
295 nm. Data were collected at 0.5 nm wavelength resolution.
doi:10.1371/journal.pone.0030257.g006
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function of these proteins [52,54], whereas others have demon-
strated contrary results [55,56]. Our results failed to find a
correlation between oligomeric size and chaperone function of
these three small heat shock proteins.
Several studies have revealed that other factors, such as
oligomerization and structural perturbation, may also be required
for the proper execution of the chaperone function of a-crystallin
[15,52,53,54,57,58]. To quantify the perturbation in the structural
stability caused by the R12A mutation, we compared the
thermodynamic stability of the Wt and mutant Hsp27 and aA-
and aB-crystallin proteins. We measured the equilibrium unfold-
ing caused by urea by following tryptophan fluorescence of the
proteins at various urea concentrations. Tryptophan fluorescence
intensities were recorded at 337 and 350 nm, respectively, at
various concentrations of urea. The data were then plotted as the
ratio of intensities at 337 and 350 nm as a function of the urea
concentration (Fig. 7). A crude estimate of the transition midpoint
(C1/2) from the sigmoidal analysis of the denaturation profiles
revealed that the C1/2 value increased from 2.34 M of urea for Wt
aA-crystallin to 2.72 M of urea for the R12A mutant (Fig. 7 and
Table 5). This increase in the C1/2 value clearly indicated that the
substitution of R12 by alanine increased the thermodynamic
stability of aA-crystallin. The C1/2 value did not change in aBR12A
and Hsp27R12A compared to the respective Wt proteins (Table 5).
These results clearly indicated that the R12 residue had a marginal
influence on the structural stability of aB-crystallin and Hsp27. To
quantify the stability against chemical denaturation, all of the
profiles were analyzed using a global three-state fitting procedure,
according to the following equation:
F
F0zF1:exp {DG0
1zm1: urea ½ 

=RTzF?:exp {DG0
2zm2 urea ½ 

=RT
1zexp {DG0
1zm1: urea ½ 

=RTzexp {DG0
2zm2: urea ½ 

=RT
where F0,F 1 and F‘ are the signal intensities for the 100% native,
the 100% intermediate and the 100% unfolded forms, respectively.
DG1
0 refers to the standard free energy change between the native
and the intermediate form, and DG2
0 refers to the standard free
energy change between the intermediate and the unfolded form.
DG
0, being the sum of DG1
0 and DG2
0, refers to the standard free
energy change of unfolding (between the native and the unfolded
form) at a urea concentration of zero. The fitted parameters are
listed in Table 5. The standard free energy change of aA-crystallin
unfolding at 25uC is 20.90 kJ/mol. This value of DG
0 is comparable
to that we and others have previously reported [42,59]. The
DG
0value for aAR12A increased to 25.54 kJ/mol, indicating an
enhancement in thermodynamic stability by ,4.5 kJ/mol. Howev-
er, the R12A substitution had no effect on the structural stability of
the other two small heat shock proteins(Table 5). In several previous
studies, investigators found that increased chaperone function of a-
crystallin was often associated with the greater structural stability of
this protein [42,58]. Therefore, we can also conclude that structural
perturbation of aA-crystallin due to the R12A mutation is a cause
for the enhancement of its chaperone function.
In summary, our study showed that the molecular basis behind
MGO-induced enhancement in the chaperone function of small heat
shock proteins is different. Although mild MGO modification
changes the conserved arginine residue (R12) in all three small heat
shock proteins, this modification is likely beneficial only for aA-
crystallin. Because aA-crystallin is predominantly found in the eye
lens, MGO-induced enhancement in the chaperone function of this
protein may be important inmaintainingthe transparency of the lens.
Table 3. Percent levels of secondary structure in the wild-
type and R12A mutants of human Hsp27 and aA- and aB-
crystallin using CONTINLL software.
Protein a-helix b-sheet b-Turn Random
aAWt 3.97 30.77 24.83 39.33
aAR12A 3.30 33.27 23.73 38.80
aBWt 3.87 36.73 22.73 35.87
aBR12A 1.83 30.17 25.23 42.13
Hsp27Wt 3.07 39.63 20.97 35.33
Hsp27R12A 3.57 34.60 23.43 38.87
doi:10.1371/journal.pone.0030257.t003
Table 4. The molar mass and the hydrodynamic radius of the
wild-type and R12A mutants of a-crystallin and Hsp27.
Proteins Molar Mass (g/mol) Hydrodynamic radius (nm)
aAWt (4.78760.003) e+5 6.9460.18
aAR12A (5.49160.005) e+5 7.6560.21
aBWt (4.80460.005) e+5 6.5960.17
aBR12A (4.31660.003) e+5 6.5260.17
Hsp27Wt (6.08560.004) e+5 7.7160.22
Hsp27R12A (5.01060.006) e+5 7.6060.26
doi:10.1371/journal.pone.0030257.t004
Figure 7. Thermodynamic stability of wild type and mutant
(R12A) aA-crystallin. Equilibrium urea denaturation profile for
0.1 mg/ml wild type and mutant proteins at 25uC. The profile is
normalized to a scale of 0 to 1. Symbols represent the experimental
data points and the solid lines represent the best fit according to the
three state model.
doi:10.1371/journal.pone.0030257.g007
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Citrate synthase (CS), lactate dehydrogenase (LDH), dithiothre-
itol (DTT), lysozyme and bovine insulin were obtained from
Sigma-Aldrich Chemical Co., LLC (St. Louis, MO, USA). CS was
dialyzed in 40 mM HEPES buffer, pH 7.4, for 24 hr before use.
2-(p-toluidino) naphthalene-6-sulfonate (TNS) was obtained from
Molecular Probes (Invitrogen, Carlsbad, CA, USA). Bovine c-
crystallin were purified from lenses, as previously described [60].
All other chemicals were of analytical grade.
Modification of proteins by MGO
Small heat shock proteins (1.0 mg/ml Hsp27 and aA- and aB-
crystallin) were incubated with either 2, 5 or 10 mM MGO (in
100 mM sodium phosphate buffer, pH 7.4) for 3 days at 37uC.
The incubated samples were subjected to SDS-PAGE (12% gel)
under reducing conditions.
Identification of hydroimidazolone by mass spectroscopy
Gel pieces containing aA-crystallin, aB-crystallin and Hsp27 cut
from the SDS-PAGE were first destained with 50% acetonitrile in
100 mM ammonium bicarbonate, and then 100% acetonitrile.
Then, the proteins were reduced by 20 mM DTT at room
temperature for 60 min, followed by the alkylation of the proteins
using 50 mM iodoacetamide for 30 min in the dark. The reaction
reagents were removed, and the gel pieces were washed with
100 mM ammonium bicarbonate and dehydrated in acetonitrile.
Sequencing grade modified trypsin (Promega, Madison, WI) in
50 mM ammonium bicarbonate was added to the dried gel pieces
and incubated at 37uC overnight. Proteolytic peptides extracted
from the gel with 50% acetonitrile in 5% formic acid were then
dried and dissolved in 0.1% formic acid. Liquid chromatography-
tandem mass spectrometric analysis of the resulting peptides was
performed on a LTQ Orbitrap Velos (Thermo Fisher Scientific,
Waltham, MA) equipped with nanoACQUITY UPLC (Waters,
Milford, MA) system. The spectra were acquired by data
dependent methods consisting of a full scan and MS/MS on the
ten most abundant precursor ions at the normalized collision
energy of 35%. The data that were obtained were submitted to
Mascot Daemon (Matrix Science, Boston, MA) for identification
of the hydroimidazolone modification on arginine residues. The
modification sites were then verified by manual interpretation of
the MS/MS spectra.
Cloning and purification of proteins
The previously described constructs for Wt aA- and aB-
crystallin were used as templates [32,58]. Hsp27 cDNA from
Thermo Scientific Open Biosystems, Huntsville, AL was used as a
template. Wild-type heat shock proteinsaA-, aB-crystallin and
Hsp27 were amplified by PCR using the following primers.
aA FP: 5-GGCCATATGGACGTGACCATCCAGCAC
aARP: 3-CCCAAGCTTGGACGAGGGAGCCGAGGTG
aB FP: 5-GGCCATATGGACATCGCCATCCACCAC
aB RP: 3-CCCAAGCTTTTTCTTGGGGGCTGCGGTGAC
Hsp27 FP: 5- GGCCATATGACCGAGCGCCGCGTCC-
CCTTCTCG
Hsp27 RP: 3- CCCAAGCTTTTACTTGGCGGCAGTCT-
CATCGGATTT
The amplified PCR product was cloned into the pET23a vector
using NdeI and HindIII restriction sites. The R12A mutants were
generated by site-directed mutagenesis using the respective Wt
cDNA as the template. The following primers were used.
aAR12AFP:5-TGGTTCAAGGCCACCCTGGGG
aAR12ARP:3-CCCCAGGGTGGCCTTGAACAA
aBR12AFP:5-TGGATCCGCGCCCCCTTCTTT
aBR12ARP:3-AAAGAAGGGGGCGCGGATCCA
Hsp27R12A FP:5-TCGCTCCTGCGGGGCCCCAGC
Hsp27R12A RP:3-GCTGGGGCCCCGCAGGAGCGA
The resulting PCR product was digested with DpnI and then
transformed into E.coli DH5alpha cells. Plasmids from the
resulting colonies were sequenced to confirm the presence of the
mutation. The recombinant proteins were overexpressed in E.coli
BL21(DE3) by induction with 250 mM IPTG when the OD600 nm
of the culture in LB broth reached ,0.6. The bacterial pellet
obtained after centrifugation at 10,000 g was suspended in 50 mM
Tris, pH 8.0 containing 50 mM NaCl, 2 mM EDTA and 10 ml/
ml of a protease inhibitor cocktail (Sigma). Lysozyme was added at
0.3 mg/ml to the cell suspension and incubated for 10 min at
37uC, followed by sonication on ice at 40 duty cycles at 30%
amplitude. Benzonase nuclease (1.0 ml) was then added to the
resulting cell lysate and incubated at 37uC in a shaker for 20 min,
which was followed by the addition of sodium deoxycholate at
1.0 mg/ml and a subsequent incubation for 10 min at 37uC. DTT
was then added to the lysate at a 5 mM concentration and
incubated for 10 min at 37uC. The cell lysate was then centrifuged
at 20,000 g for 30 min at 4uC. DNA in the lysate was precipitated
by adding 0.2% polyethyleneimine followed by centrifugation at
20,000 g for 15 min. Ammonium sulfate was added to the lysate to
reach 70% saturation, and the suspension was then left at 4uC
overnight and then centrifuged at 20,000 g for 5 min. The
resulting pellet was suspended in 50 mM sodium phosphate buffer
(pH 7.4), which contained 150 mM NaCl and 5 mM DTT, and
was then centrifuged at 20,000 g for 5 min. The supernatant was
filtered with a 0.45 mm filter and applied onto a Superdex-200
prep grade (GE Healthcare, WI) gel filtration column that was pre-
equilibrated with 50 mM sodium phosphate buffer pH 7.4.
Fractions of 2.0 ml were collected and their OD280 nm was
recorded. The peak fractions were pooled and dialyzed overnight
at 4uCin 20 mM Tris, pH 8.0 that contained 0.1 mM EDTA. The
dialyzed sample was applied onto a Q-Sepharose (GE Healthcare,
WI) anion exchange column equilibrated with 20 mM Tris,
pH 8.0 with 0.1 mM EDTA. The bound protein was eluted with a
0–1 M NaCl gradient. The protein peak fractions were pooled and
dialyzed in PBS containing 0.1 mM EDTA and stored in aliquots
at 280uC.
Determination of molecular mass by multi-angle light
scattering
The molar mass and the hydrodynamic radius of wild-type and
R12A mutants of a-crystallin and Hsp27 were estimated by multi-
angle light scattering measurements as previously described
[32,58]. The molar mass (Mw) and the hydrodynamic radius
Table 5. The C1/2 and the DG
0 values of the wild-type and
R12A mutants of a-crystallin and Hsp27 at 25uC.
Proteins C1/2 (M) DG
0 (kJ/mole)
aAWt 2.34 20.9060.62
aAR12A 2.72 25.5460.66
aBWt 2.41 22.4460.21
aBR12A 2.43 22.3460.78
Hsp27Wt 2.38 21.3760.44
Hsp27R12A 2.36 21.3860.56
doi:10.1371/journal.pone.0030257.t005
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(5.3.4) software developed by Wyatt Technology Corp.
Determination of secondary and tertiary structure by CD
spectroscopy
The far-UV CD spectra were measured at 25uC using a Jasco
815 spectropolarimeter (Jasco, Inc., Japan). The spectra were
collected from 250 to 200 nm using a cylindrical quartz cell of
2 mm path length. Proteins (0.2 mg/ml) were dissolved in 10 mM
phosphate buffer (pH 7.2). The resultant spectra after five scans
were analyzed for secondary structure by the curve-fitting program
CONTINLL [61].
The near-UV CD spectra were measured at 25uC using the
same spectropolarimeter as stated above. The spectra were
measured with a 0.5 mg/ml protein solution in 50 mM
phosphate buffer (pH 7.2). The reported spectra were the average
of 5 scans.
Tryptophan fluorescence measurements
The intrinsic tryptophan fluorescence spectra of proteins
(0.1 mg/ml) in 50 mM phosphate buffer (pH 7.2) at 25uC were
recorded using a Fluoromax-4P spectrofluorometer (Horiba
Jobin Mayer, USA). The excitation wavelength was set to
295 nm, and the emission spectra were recorded between 310
and 400 nm. Data were collected at a 0.5 nm wavelength
resolution.
Estimation of Surface hydrophobicity
The surface hydrophobicity of the different protein solutions
(0.1 mg/ml of the wild-type and R12A mutants) was measured
using a hydrophobic probe, TNS (emission: 350–520 nm,
excitation: 320 nm), as previously described [33]. The concentra-
tion of TNS that was used was 100 mM.
Chaperone assays
The chaperone assays were carried out as previously described
[62]. The ratios (w/w) of aA-crystallin to CS, c-crystallin and
LDH were 1:10, 1:12 and 1:28, respectively. The ratios (w/w) of
aB-crystallin to CS, c-crystallin and LDH were 1:4, 1:15 and 1:28,
respectively. The ratios (w/w) of Hsp27 to CS, c-crystallin and
LDH were 1:10, 1:37 and 1:28, respectively.
Equilibrium binding study
The chaperone-substrate binding study was performed by a
membrane filtration method that we recently described [58].
Briefly, wild-type or mutant Hsp27 and aA- and aB-crystallin
(12.5 mM) were incubated at 60uC for 1 hr with 2–18 mM c-
crystallin in 50 mM phosphate buffer containing 100 mM NaCl
(pH 7.2). After equilibration, the incubation mixture was spun
through a Microcon centrifugal device (4,000 g) fitted with a 100-
kDa cut off membrane filter to separate the unbound substrate.
The number of binding sites (n) and dissociation constant (Kd)
were determined by a similar procedure [33,42,58].
Determination of structural stability of proteins
The structural stability of Wt and mutant proteins was
determined by equilibrium chemical denaturation experiment.
Wt and mutant proteins (0.05 mg/ml in 50 mM phosphate buffer,
pH 7.5) were incubated separately with various urea concentra-
tions (0–7 M) for 18 hrs at 25uC. Tryptophan fluorescence spectra
of all samples were taken in the 300–400 nm region using 295 nm
as the excitation wavelength. The equilibrium unfolding profile
was fitted according to a three state model [42,53,58].
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